Abingdon Health Plc (AIM:ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX 7.50
-0.01 (-0.15%)
Feb 21, 2025, 4:35 PM GMT+1
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 28.89 million as of February 21, 2025. Its market cap has increased by 13.11% in one year.
Market Cap
28.89M
Enterprise Value
28.50M
Revenue
6.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.50
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 28.89M, a decrease of -71.39%. That is a compound annual growth rate of -25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 28.89M | -3.23% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |